iRhythm Technologies (IRTC) Competitors $109.10 -1.06 (-0.96%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$109.24 +0.15 (+0.13%) As of 08:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRTC vs. SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, NARI, NVST, and PRCTShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Solventum Smith & Nephew Penumbra Glaukos Stevanato Group Bausch + Lomb Inspire Medical Systems Inari Medical Envista PROCEPT BioRobotics Solventum (NYSE:SOLV) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Is SOLV or IRTC more profitable? Solventum has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Solventum's return on equity of 0.00% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A iRhythm Technologies -19.14%-118.83%-11.34% Does the MarketBeat Community prefer SOLV or IRTC? iRhythm Technologies received 408 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 66.07% of users gave iRhythm Technologies an outperform vote while only 4.35% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes14.35%Underperform Votes2295.65% iRhythm TechnologiesOutperform Votes40966.07% Underperform Votes21033.93% Do analysts rate SOLV or IRTC? Solventum currently has a consensus target price of $78.86, indicating a potential downside of 1.51%. iRhythm Technologies has a consensus target price of $119.73, indicating a potential upside of 9.74%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82 Which has better earnings & valuation, SOLV or IRTC? Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.26B1.67$475.07M$2.7529.12iRhythm Technologies$591.84M5.79-$123.41M-$3.64-29.97 Does the media prefer SOLV or IRTC? In the previous week, Solventum had 57 more articles in the media than iRhythm Technologies. MarketBeat recorded 62 mentions for Solventum and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.00 beat Solventum's score of 0.68 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 21 Very Positive mention(s) 4 Positive mention(s) 25 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySolventum beats iRhythm Technologies on 8 of the 15 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.43B$4.58B$5.81B$8.43BDividend YieldN/A36.92%4.76%3.97%P/E Ratio-29.9730.3924.9319.24Price / Sales5.7950.34375.35110.20Price / CashN/A51.0838.0534.58Price / Book15.936.267.374.28Net Income-$123.41M$67.64M$3.18B$247.04M7 Day Performance-4.22%-5.18%-2.92%-3.26%1 Month Performance-1.58%-9.68%-6.83%-6.57%1 Year Performance0.05%10.60%12.61%4.01% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies0.7408 of 5 stars$109.10-1.0%$119.73+9.7%-9.5%$3.43B$591.84M-29.972,000Positive NewsSOLVSolventum1.1933 of 5 stars$76.30+4.5%$68.29-10.5%N/A$13.18B$8.26B0.0022,000Analyst ForecastSNNSmith & Nephew2.9363 of 5 stars$26.31+0.7%N/A+12.2%$11.50B$5.55B12.1818,452Dividend IncreasePENPenumbra4.1055 of 5 stars$287.81-1.3%$292.64+1.7%+20.8%$11.09B$1.19B846.494,200GKOSGlaukos4.4374 of 5 stars$124.34-1.2%$163.25+31.3%+22.9%$6.86B$383.48M-43.32780High Trading VolumeSTVNStevanato Group0.869 of 5 stars€20.95+0.2%N/A-45.1%$6.34B$1.09B44.575,635Positive NewsBLCOBausch + Lomb4.3481 of 5 stars$15.83+0.5%$19.83+25.3%-3.7%$5.58B$4.79B-17.3913,300Short Interest ↓INSPInspire Medical Systems4.7727 of 5 stars$186.51+5.2%$228.82+22.7%-0.4%$5.53B$802.80M107.811,246Positive NewsNARIInari Medical1.6725 of 5 stars$79.97+0.1%$68.00-15.0%N/A$4.68B$493.63M-59.241,300High Trading VolumeNVSTEnvista3.19 of 5 stars$21.36+2.4%$20.21-5.4%-9.2%$3.68B$2.51B-3.2912,300Positive NewsPRCTPROCEPT BioRobotics3.0546 of 5 stars$65.15+4.7%$97.86+50.2%+23.5%$3.40B$199.84M-33.41430Earnings ReportPositive News Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Stevanato Group Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives Inari Medical Alternatives Envista Alternatives PROCEPT BioRobotics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRTC) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
